Imaging study for lung cancer outcomes
Part of Cancer, Lungs & breathing clinical trials.
This study looks at medical images from people with lung cancer to see how image findings relate to outcomes. It may help doctors better understand which imaging features predict results for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of lung cancer
- You must be receiving treatment at the University of Texas Southwestern Radiation Oncology department
- OR you must be treated at Parkland Memorial Hospital
- There are no other “absolute” reasons you will be excluded if you meet the requirements above
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers,” which are measurable signs in the body (often in blood or samples), in people with lung or other chest cancers. It may help researchers better understand these cancers and improve how they’re diagnosed or tracked.
This study looks at how lung cancer screening practices relate to the types and stages of lung cancer patients develop. Researchers want to understand whether earlier detection through screening changes what kinds of lung cancer people get, which could help improve screening strategies in the future.
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This is an observational study of people with lung cancer. The goal is to better understand care patterns and outcomes; joining would involve giving consent and answering study questions.
This trial compares a two-step nuclear imaging scan (SPECT/CT) versus a PET/CT scan to see which works better for lung cancer. It may help guide doctors on the most useful imaging approach before you start lung-cancer treatment.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.